Striking increase of thin melanomas contrasts with stable incidence of thick melanomas

Archives of Dermatology

Volumn 135, Issue 12, 1999, Pages 1451-1456

  Lipsker, Dan M ^a   Hedelin, Guy ^b   Heid, Ernest ^a   Grosshans, Edouard M ^a   Cribier, Bernard J ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CONTROLLED STUDY; FEMALE; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; SEX RATIO;

EID: 0032779053     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.135.12.1451     Document Type: Article

References (28)

1. Boyle P, Maisonneuve P, Doré JF. Epidemiology of malignant melanoma. Br Med Bull. 1995;51:523-547.
2. MacKie RM, Hole D. Hunter JAA, et al. Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94. BMJ. 1997;315:1117-1121.
3. Herd RM, Cooper EJ, Hunter JAA, et al. Cutaneous malignant melanoma: publicity, screening clinics and survival: the Edinburgh experience 1982-90. Br J Dermatol. 1995;132:563-570.
4. MacLennan R, Green AC, McLeod GR, Martin NG. Increasing incidence of cutaneous melanoma in Queensland, Australia. J Natl Cancer Inst. 1992;84:1427-1432.
5. Laplanche A, Benhamou E. Estimation de l'incidence des cancers en France. Bull Cancer. 1991;78:405-414.
6. Estève J, Kricker A, Ferlay J, Parkin DM. Facts and figures of cancer in the European Community. IARC Monogr Eval Carcinog Risks Hum. 1993.
7. Thiele H, Schöls A, Scuppe HC, Jungblut RM, Goerz G. Das maligne melanom: klinische und diagnostische Erfahrungen. Z Hautkr. 1993;68:311-314.
8. Rompel R, Weiss H, Zöfel P, Petres J. Epidemiologie des malignen Melanoms in Stadt- und Landbevölkerung. Z Hautkr. 1997;72:29-33.
9. Baccard M, Havard S, Souques M. Prospective study of the incidence of melanoma in the Paris region in 1994. Melanoma Res. 1997;7:335-338.
10. Lipsker D, Heid E, Grosshans E, Cribier B. Le mélanome au CHU de Strasbourg: etude sur 30 ans. Ann Dermatol Venereol. 1998;125:241-246.
11. Buzaid AC, Ross MI, Balch CM, et al. Critical analysis of the current American Joint Committee on Cancer Staging System for Cutaneous Melanoma and Proposal of a New Staging System. J Clin Oncol. 1997;15:1039-1051.
12. Roush GC, Berwick M, Koh HK, MacKie RM. Screening for melanoma. In: Balch CM, Houghton AN, Milton GW, Sober AJ, Soong SJ, eds. Cutaneous Melanoma. 2nd ed. Philadelphia, Pa: Lippincott-Williams & Wilkins: 1992;70-81.
13. MacKie RM. Melanoma prevention and early detection. Br Med Bull. 1995;51: 570-583.
14. Doherty VR, MacKie RM. Experience of a public education programme on early detection of cutaneous malignant melanoma. BMJ. 1988;287:388-391.
15. MacKie RM, Hole D. Audit of public education campaign to encourage earlier detection of malignant melanoma. BMJ. 1992;304:1012-1015.
16. Cristofolini M, Bianchi R, Sebastiana B, et al. Analysis of the cost-effectiveness ratio of the health campaign for the early diagnosis of cutaneous melanoma in Trentino, Italy. Cancer. 1993;71:370-374.
17. Rampen FHJ, van Huystee BEWL, Kiemeney LALM. Melanoma/skin cancer screening clinics: experiences in the Netherlands. J Am Acad Dermatol. 1991;25:776-777.
18. Hoffmann K, Dirschka T, Schatz H, Segerling M, Tiemann T, Hoffmann A. A local education campaign on early diagnosis of malignant melanoma. Eur J Epidemiol. 1993;9:591-598.
19. Koh HK, Norton LA, Geller AC, et al. Evaluation of the American Academy of Dermatology's national skin cancer and early detection and screening program. J Am Acad Dermatol. 1996;34:971-978.
20. Guerry D IV, Synnestvedt M, Elder DE, Schultz E. Lessons from tumor progression: the invasive radial growth phase of melanoma is common, incapable of metastastis, and indolent. J Invest Dermatol. 1993;100(suppl):342S-345S.
21. Kerbel RS, Kobayashi H, Graham CH, Lu C. Analysis and significance of the malignant eclipse during the progression of primary cutaneous human melanomas. J Invest Dermatol. 1996;103:183-187.
22. In: Francis B, Green M, Payne C, eds. GLIM 4-The Statistical System for Generalised Linear Interactive Modelling. Oxford, England: Clarendon Press; 1994.
23. Van der Esch EP, Muir CS, Nectoux J, et al. Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely. Int J Cancer. 1991;47:483-489.
24. Berwick M. Epidemiology: current trends, risk factors, and enviromental concerns. In: Balch CM, Houghton AN, Sober AJ, Soong SJ, eds. Cutaneous Melanoma. 3rd ed. St Louis, Mo: Quality Medical Publishing Inc; 1998;551-571.
25. Burton RC, Armstrong BK. Recent incidence trends imply a nonmetastasizing form of invasive melanoma. Melanoma Res. 1994;4:107-113.
26. Swerlick RA, Chen S. The melanoma epidemic: is increased surveillance the solution or the problem? Arch Dermatol. 1996;132:881-884.
27. Dunkley MP, Morris AM. Cutaneous malignant melanoma: audit of the diagnostic process. Ann R Coll Surg Engl. 1991;73:248-252.
28. Helsing P, Faye R, Langmark F. Cutaneous malignant melanoma: correlation between tumor characteristics and diagnostic delay in Norwegian patients. Eur J Dermatol. 1997;7:359-361.